2393-6797 2393-6797 S2393-67972017000300024 10.26445/rmu.2.3.2 Uruguay 00 12 2017 00 12 2017 2 3 24 50

1 2012 380 9859 9859 2095-128 2 2015 36 40 40 2696-705 3 2004 4 2016 37 39 39 2999-3058 5 2014 63 25 25 2889-934 6 Cholesterol Treatment Trialists' (CTT) Collaboration 2010 376 9753 9753 1670-81 7 2012 380 9841 9841 581-90 8 National Cholesterol Education Program (NCEP) Expert Panel on Detection Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) 2002 106 25 25 3143-421 9 2016 68 1 1 92-125 10 AIM-HIGH Investigators 2011 365 24 24 2255-67 11 The ARIC investigators 1989 129 4 4 687-702 12 1991 1 3 3 263-76 13 1988 41 11 11 1105-16 14 1963 107 539-56 15 1979 110 3 3 281-90 16 1994 344 8934 8934 1383-9 17 1996 335 14 14 1001-9 18 2005 19 2015 372 1533-4406 20 2004 350 15 15 1495-504 21 Heart Protection Study Collaborative Group 2003 361 9374 9374 2005-16 22 Study of the Effectiveness of Additional Reductions in Cholesterol and Homocysteine (SEARCH) Collaborative Group 2010 376 9753 23 2006 355 6 6 549-59 24 2005 352 14 14 1425-35 25 Cholesterol Treatment Trialists (CTT) Collaborators 2008 371 9607 9607 117-25 26 2005 366 9493 9493 1267-78 27 2014 384 9943 9943 607-17 28. 2004 364 9435 9435 685-96 29 2005 28 5 5 1151-7 30 Heart Protection Study Collaborative Group 2003 361 9374 9374 2005-16 31 Cholesterol Treatment Trialists (CTT) Collaboration 2015 385 9976 9976 1397-405 32 1994 90 4 4 1679-87 33 2006 368 9542 9542 1155-63 34 1998 279 20 20 1615-22 35 2007 92 12 12 4671-7 36 1996 101 6 6 627-34 37 1996 240 1 1 13-22 38 2003 25 4 4 1107-22 39 2005 178 2 2 387-97 40 2008 359 21 21 2195-207 41 1995 92 7 7 1758-64 42 2007 297 12 12 1344-53 43 2004 35 12 12 2807-12 44 2004 110 18 18 2809-16 45 1995 333 20 20 1301-7 46 2013 CD004816 47 HPS2-THRIVE Collaborative Group 2014 371 3 3 203-12 48 2012 2 2 198-205 49 2015 132 17 17 1648-66 50 2016 12 421-33 51 2015 372 16 16 1489-99 52 2015 372 16 16 1500-9 53 2016 45 1 1 39-54 54 2014 129 9 9 1022-32 55 2016 37 29 29 2315-81 56 2009 54 14 14 1209-27 57 2012 308 8 8 788-95 58 2014 64 5 5 485-94 59 2014 89 9 9 1257-78 60 2015 38 9 9 520-6 61 2005 165 22 22 2671-6 62 2013 29 12 12 1553-68 63 2002 105 20 20 2341-6 64 2008 9 4 4 223-8 65 2013 158 12 12 869-76 66 2008 101 12 12 1747-8 67 2009 103 3 3 393-4 68 2012 56 2 2 374-80 69 2012 46 4 4 549-57 70 2015 33 2 2 245-56 71 2012 43 8 8 2149-56 72 2014 129 25^s2 25^s2 2 S76-99 73 2003 361 9364 9364 1149-58 74 2005 28 5 5 1151-7 75 Heart Protection Study Collaborative Group 2002 360 9326 9326 7-22 76 Cholesterol Treatment Trialists (CTT) Collaborators 2008 371 9607 9607 117-25 77 2009 26 2 2 142-8 78 2009 53 4 4 316-22 79 ACCORD Study Group 2010 362 17 17 1563-74 80 2011 32 11 11 1345-61 81 2012 97 9 9 2969-89 82 2014 2 3 3 289-97 83 2008 372 9645 9645 1231-9 84 2015 17 4 4 434-41 85 Chronic Kidney Disease Prognosis Consortium 2010 375 9731 9731 2073-81 86 2014 5 CD007784 87 2011 377 9784 9784 2181-92 88 2005 353 3 3 238-48 89 2009 360 14 14 1395-407 90 2014 85 6 6 1303-9 91 2001 16 8 8 1545-9 92 2003 42 5 5 1050-65 93 2003 361 9374 9374 2024-31 94 2014 370 15 15 1422-31 95 2012 380 9841 9841 581-90 96 2012 2012 930139 97 1993 269 23 23 3015-23 98 2010 69 2 2 325-31 99 2014 35 21 21 1373-81